Enlite, a Mumbai-based infra automation startup, raised Rs 46 crore (about $5 million) in its maiden institutional funding round led by Avaana Capital. The funds will be used to expand into international markets, enhance AI capabilities, and scale deployments in infrastructure sectors. Founded in 2017 by Gaurav Bali and Garima Bharadwaj, the company provides real-time building automation systems and has partnered with major clients like Prestige Group and Fairmont Mumbai.

The article discusses the Bevacizumab pipeline, highlighting 25+ companies developing 30+ therapies for cancer treatment. It details FDA approval of JobevneTM (a biosimilar of Avastin) by Biocon Biologics in April 2025, and outlines clinical trials for biosimilars and novel therapies like Mvasi (Amgen) and HD204 (Prestige Biopharma). The report also categorizes therapies by route of administration, molecule type, and development stage.

On July 17, six stocks in the NSE list with a market cap of Rs 1,000 crore formed a 'White Marubozu' bullish candlestick pattern, indicating strong buying pressure. The stocks included Hitachi Energy India, Zydus Wellness, Craftsman Automation, Prudent Corporate Advisory Services, Avanti Feeds, and Prestige Estates Projects, all showing positive price movements.

The Indian stock market opened flat on 18 July amid weak investor sentiment driven by Foreign Portfolio Investor (FPI) selling and weak IT sector earnings. Analyst Rajesh Palviya of Axis Securities recommended three stocks—Torrent Pharmaceuticals, Prestige Estates Projects, and V-Guard Industries—based on technical analysis, with price targets and support levels provided for each.

The article provides short-term trading strategies for several Indian stocks, including Prestige Estates Projects, Sterling and Wilson Renewable Energy, and others, based on technical analysis and market trends.